Media Center Found (709)
Array ( [cache_time] => 0 [counts_time] => 0.0065760612487793 [query_time] => 0.0047791004180908 [total_time] => 0.01135516166687 )
April 17, 2007

Tiltan attacks cancer using four different materials 

 

More
April 12, 2007

The company has developed a method for applying transgenic tobacco to produce human recombinant collagen.

More
April 11, 2007

CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement

More
April 10, 2007

CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement

More
April 5, 2007

Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis

 

More
April 4, 2007

Four years after the first information on featherless broiler research was known, the attention of the public and world media was attracted. Commercial trials show the big advantage over their feathered relatives, especially when kept in tropical...

More
March 25, 2007

Bioline will develop a new drug based on the technology of Prof. Hillel Bercovier and Dr. Ayelet Barenholz of the Hebrew university. 

 

More
February 28, 2007

The agreement is reportedly worth several million dollars. 

 

More
January 30, 2007

Yissum subsidiary Target-In and Indian company Century Pharmaceuticals will jointly develop a new drug for asthma and allergy, which will be based on the molecule developed by the Israel company.  

(Hebrew article attached)

More
January 30, 2007

Over 150 people attended the opening of the Hebrew University's new Center for Converging Sciences and Technologies, which aims to bridge the gaps that exist among different research fields.

More
January 30, 2007

A facility for cross-disciplinary scientific research on a more comprehensive scale than has been

attempted anywhere is being launched by the Hebrew University of Jerusalem, in cooperation

with Yissum, the technology transfer company of the...

More
January 20, 2007

These yellow cherry tomato seeds, named Summer Sun, were developed by Hazera

Genetics, part of the French-based global group Vilmorin Clause & Cie, in

collaboration with the Faculty of Agriculture at the Hebrew University.

More
December 25, 2006

This grant was received from the World Fund for Juvenile Diabetes Research and D-Cure. (Hebrew article attached)

More
December 25, 2006

This grant was received from the World Fund for Juvenile Diabetes Research and D-Cure.

More
October 31, 2006

Yissum will aid Kazakhstan in establishing technology transfer facilities as part of the Kazakhstan National Center for Biotechnology.  (Hebrew article attached)

More
October 30, 2006

Yissum will aid Kazakhstan in establishing technology transfer facilities as part of the Kazakhstan National Center for Biotechnology.

More
August 8, 2006

Biocancell Therapeutics Ltd.’s IPO benefited from both investor confidence in the company and lucky timing. Scheduled during the war, it was held on the day the cease-fire went into effect, when trading on the Tel Aviv Stock Exchange (TASE) was...

More
May 29, 2006

Professors Chaim Gilon, Amnon Hoffman and Shimon Benita were awarded prizes for the best scientific posters at Yissum's poster exhibition at Biomed 2006

More
March 15, 2006

Yissum has developed state of the art software for Technology Transfer Management. The software, which is built on an SQL database under DOT.NET Framework, allows managing; patents, agreements, projects, contacts, companies and much more. The...

More
December 16, 2005

An Israeli university that numbers physicist Albert Einstein among its founders has become a

crucible on transforming research into successful products.

More